predictions for end of 2014, page-11

This is the quote from Biomerieux half yearly discussing the partnership with Philips and Magnotech :

"Partnership with Philips in automated Point-of-Care
In January 2010, Philips and bioMérieux began collaborating to jointly develop fully automated handheld diagnostic testing solutions for hospital use that can be deployed at the point-of-care – i.e. close to the patient.

Given the challenges encountered in developing Troponin solutions delivering performance comparable to central laboratory analyzers, both partners have signed an addendum to the original agreement.

It provides that Philips will separately pursue development of the Troponin assay and system. bioMérieux will discontinue its own assay development during this development period, but provide an undisclosed level of funding toward the development. In addition, this addendum maintains bioMérieux’s rights to re-engage on a non-exclusive basis, until March 31, 2014."

If POC1 is Philips then i would say it is GO TIME!